BioCentury
ARTICLE | Finance

Turn up the volume

November 9, 1998 8:00 AM UTC

Geron (GERN) - which has 10.9 million shares in the float of its 12.5 million shares outstanding - traded 41.1 million shares on Friday, the day after publication of a Science paper disclosing that a University of Wisconsin researcher had isolated human embryonic stem cells from in vitro fertilized human embryos (see Cover Story). GERN has an exclusive license to the technology...